Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- PE ratio
- —
- Forward PE
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 4,900
- Avg volume
- 2,960
- Day's range
- $1.31 – $1.67
- Shares out
- —
- Stochastic %K
- 0%
- Beta
- —
- Analysts
- Strong Buy
- Price target
- —
Company profile
Aeternum Health Inc. develops and commercializes healthcare and longevity-focused products and solutions. It offers a peptide mix in development for longevity and anti-aging, related intellectual property, know-how, and data used for commercialization of longevity-focused healthcare solutions. It serves healthcare and longevity sector. The company sells its products through Internet. It also engages in mining of crit...
Show more
Aeternum Health Inc. develops and commercializes healthcare and longevity-focused products and solutions. It offers a peptide mix in development for longevity and anti-aging, related intellectual property, know-how, and data used for commercialization of longevity-focused healthcare solutions. It serves healthcare and longevity sector. The company sells its products through Internet. It also engages in mining of critical minerals. The company was founded in 2019 and is based in Washington, District Of Columbia.
- Industry
- Specialty Retail
- Sector
- Consumer Cyclical
- Phone
- (202) 580-6500
- Website
- https://aeternum.site
- Address
- 601 Pennsylvania Avenue NW, South Building Suite 900, Washington, United States
Latest news
No headlines yet.
